Verona Pharma plc (VRP.L) (LON:VRP – Get Free Report)’s share price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 55 ($0.70) and traded as low as GBX 50 ($0.64). Verona Pharma plc (VRP.L) shares last traded at GBX 55 ($0.70), with a volume of 70,791 shares.
Verona Pharma plc (VRP.L) Trading Up 5.8 %
The firm has a market capitalization of £228.00 million and a price-to-earnings ratio of -1.68. The company has a fifty day moving average price of GBX 55 and a two-hundred day moving average price of GBX 55. The company has a current ratio of 2.99, a quick ratio of 2.47 and a debt-to-equity ratio of 6.85.
Verona Pharma plc (VRP.L) Company Profile
Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.
See Also
- Five stocks we like better than Verona Pharma plc (VRP.L)
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Sarepta Therapeutics Stock Soars on FDA Approval
- 3 Grocery Stocks That Are Proving They Are Still Essential
- CarMax: A Market Melt-Up Waiting to Happen for this Stock
- Trading Stocks: RSI and Why it’s Useful
- 3 Solar Stocks to Watch that are Building the Green Energy Future
Receive News & Ratings for Verona Pharma plc (VRP.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verona Pharma plc (VRP.L) and related companies with MarketBeat.com's FREE daily email newsletter.